External Source

Data Leading To The Approval Of Adjuvant Therapy

2019 1:18
Synopsis
In this video, Lisa A. Kottschade, APRN, MSN, CNP, of the Mayo Clinic, discusses the data leading to the approval of adjuvant ...

You Might Also Like

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Meisel & Dr. Soliman 1:03:44
New & Supporting Data For Optimizing Therapy In Her2+ Breast...
2021
Targeted Therapy: Adjuvant Approval 1:18
Targeted Therapy: Adjuvant Approval
2024
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Bagegni & Dr. Gradishar 55:48
New & Supporting Data For Optimizing Therapy In Her2+ Breast...
2021
Adjuvant Therapies in RCC: Are New Data Practice Changing? 3:30
Adjuvant Therapies In Rcc: Are New Data Practice Changing?
2023
Dr. Luke on the FDA Approval of Adjuvant Nivolumab in Melanoma 1:49
Dr. Luke On The Fda Approval Of Adjuvant Nivolumab In Melano...
2018
Copy of Dr. Weber on the FDA Approval of Adjuvant Dabrafenib/Trametinib in BRAF-Mutant Melanoma 0:18
Copy Of Dr. Weber On The Fda Approval Of Adjuvant Dabrafenib...
2018
Dr. Tarhini Discusses Adjuvant Therapy for Melanoma 2:06
Dr. Tarhini Discusses Adjuvant Therapy For Melanoma
2018
Neoadjuvant Therapy and Adjuvant Therapy (pre and post-surgery) for Melanoma 26:05
Neoadjuvant Therapy And Adjuvant Therapy (pre And Post-surge...
2023
Recent Approvals: Cemiplimab Approval for Metastatic or Locally Advanced Cutaneous Squamous Cell ... 5:38
Recent Approvals: Cemiplimab Approval For Metastatic Or Loca...
2024
Understanding Adjuvant Therapy After Melanoma Surgery 18:17
Understanding Adjuvant Therapy After Melanoma Surgery
2018
Dr. Weber on the FDA Approval of Adjuvant Dabrafenib/Trametinib in BRAF-Mutant Melanoma 1:11
Dr. Weber On The Fda Approval Of Adjuvant Dabrafenib/trameti...
2018
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.